{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:14:59Z","timestamp":1761862499231},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ygyno.2005.09.009","type":"journal-article","created":{"date-parts":[[2005,11,5]],"date-time":"2005-11-05T12:38:03Z","timestamp":1131194283000},"page":"385-388","source":"Crossref","is-referenced-by-count":38,"title":["Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group"],"prefix":"10.1016","volume":"100","author":[{"given":"Cheryl A.","family":"Brewer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Nagourney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Scott","family":"McMeekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikant","family":"Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Zweizig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.09.009_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00130404-200309000-00013","article-title":"The role of chemotherapy in the management of carcinoma of the cervix","volume":"9","author":"Thigpen","year":"2003","journal-title":"Cancer J."},{"key":"10.1016\/j.ygyno.2005.09.009_bib2","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/cncr.11676","article-title":"Innovations in the treatment of invasive cervical cancer","volume":"98","author":"Stehman","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.09.009_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00130404-200309000-00011","article-title":"State IIB\u2013IVA cancer of the cervix","volume":"9","author":"Rose","year":"2003","journal-title":"Cancer J."},{"key":"10.1016\/j.ygyno.2005.09.009_bib4","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L","article-title":"Carcinoma of the cervix treated with radiation therapy: I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group","volume":"67","author":"Stehman","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2005.09.009_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00004347-199404000-00001","article-title":"Evaluation and comparison of histopathologic grading systems of epithelial carcinoma of the uterine cervix: Gynecologic Oncology Group studies","volume":"13","author":"Stock","year":"1994","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1525-1438.2003.13325.x","article-title":"Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix","volume":"4","author":"Eralp","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2005.09.009_bib7","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1200\/JCO.2000.18.11.2245","article-title":"Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients","volume":"18","author":"Nagourney","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/gyno.2002.6855","article-title":"Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer subjects","volume":"88","author":"Nagourney","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2002.6850","article-title":"Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum and multidrug-resistant ovarian and peritoneal carcinoma","volume":"88","author":"Rose","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3816\/CLM.2004.n.009","article-title":"Pilot study of fixed-infusion rate gemcitabine with cisplatin and dexamethasone in patients with relapsed of refractory lymphoma","volume":"5","author":"Emmanouilides","year":"2004","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.ygyno.2005.09.009_bib11","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/carcin\/14.10.2177","article-title":"Cisplatin sensitivity\/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3","volume":"14","author":"Lee","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2005.09.009_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2005.09.009_bib13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0006-2952(00)00448-2","article-title":"Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues","volume":"60","author":"Dabholkar","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib14","first-page":"3000","article-title":"Cis-diamminedichloroplatinum (II) induced adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum (II)","volume":"47","author":"Fichtinger-Schepman","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2005.09.009_bib15","unstructured":"National Cancer Institute. Digest page: NCI clinical announcement on cervical cancer. Available from URL: http:\/\/www.cancer.gov\/clinicaltrials\/digestpage\/cervical-cancer-announcement."},{"key":"10.1016\/j.ygyno.2005.09.009_bib16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stages IIB\u2013IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib17","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.09.009_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2005.09.009_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky Stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ygyno.2005.09.009_bib21","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2004.04.170","article-title":"Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"22","author":"Moore","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2005.09.009_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/gyno.1999.5671","article-title":"Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the Gynecologic Oncology Group","volume":"76","author":"Schilder","year":"2000","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825805007894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T08:10:33Z","timestamp":1554365433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825805007894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0090825805007894"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.09.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}